抗VEGF药物对糖尿病视网膜病变-微动脉瘤的影响:一项相关性研究
Tianhang Li1, Zhaohui Gu2, Yueling Zhang3
1Tianhang Li, Ward of Ophthalmology 2nd Department, Baoding No.1 Central Hospital, Baoing 071000, Hebei, China.
Pakistan journal of medical sciences
|December 5, 2024
概括
抗血管内皮生长因子 (VEGF) 药物显著改善了糖尿病视网膜病变 (DR) 的结果. 早期治疗减少了微动脉瘤和改善视力,在患有黄斑的患者中显示出高临床疗效.
科学领域:
- 眼科医生 眼科 眼科
- 医学研究 医学研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病视网膜病变 (DR) 是导致视力丧失的主要原因.
- 黄斑是DR的常见并发症之一.
- 视网膜微动脉瘤是DR严重程度的关键指标.
研究的目的:
- 评估抗血管内皮生长因子 (VEGF) 药物在治疗糖尿病视网膜病变 (DR) 的疗效.
- 评估抗VEGF治疗对视网膜微动脉瘤和DR患者视觉预后的影响.
主要方法:
- 一年来对120名DR患者进行了回顾性研究.
- 对照组 (常规治疗) 和注射组 (常规治疗+静脉内抗VEGF) 的比较.
- 对视网膜微动脉瘤,最佳校正视敏度 (BCVA) 和中枢视网膜厚度 (CRT) 变化的分析.
主要成果:
- 反VEGF注射组显示了95%的总疗效,对照组为80% (p<0.05).
- 在注射组治疗后观察到CRT和微动脉瘤数量的显著减少.
- 注射组的BCVA有所改善,而对照组没有显著变化.
结论:
- 早期的静脉内抗VEGF治疗对带有黄斑的DR非常有效.
- 治疗改善 fundus 病变,减少 CRT 和微动脉瘤,并增强 BCVA.
- 抗VEGF药物为治疗糖尿病视网膜病变提供了一个有前途的治疗选择.
更多相关视频
12:28Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
Published on: March 12, 2022
3.5K
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
1.0K
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...